Real-time enrollment status for this advanced solid tumor clinical trial
Current Status
Recruiting
Checked: July 22, 2026 at 6:30 PM UTC
| NCT Number | NCT05204862 |
| Recruiting Status | Recruiting |
| Condition | Advanced Solid Tumor |
| Phase | PHASE1 |
| Target Enrollment | 240 participants |
| Active Locations | 1 sites in the US |
| Sponsor | TiumBio Co., Ltd. |
| Last Updated on CT.gov | April 3, 2023 (Apr 3, 2023) |
As of July 22, 2026: Clinical trial NCT05204862 is currently recruiting participants. This phase1 study for advanced solid tumor is actively seeking new participants at 1 location across the United States. The study is sponsored by TiumBio Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05204862 is actively recruiting participants as of July 22, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05204862 was last updated Apr 3, 2023 (April 3, 2023). HelloStudys verifies this status automatically.